Editors' Note: This article covers a stock trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.
It's hard to find undervalued micro-caps in this fully valued market, but it's even harder to find profitable ones. But we managed to discover a profitable and undervalued micro-cap operating in the biotech industry: Bioanalytical Systems (BASI). No one on Seeking Alpha has previously covered the stock, and an online search hardly provided us any information as well. Our experience is that such an under-the-radar profile often creates an interesting trade opportunity as we, after hours of research, found out is the case here. We...
Only subscribers can access this article, which is part of the PRO research library covering 3,587 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: